Primary or Recurrent Breast Carcinoma Active Not Recruiting Phase 2 Trials for Fludeoxyglucose (18F) (DB09502)

IndicationStatusPhase
DBCOND0135669 (Primary or Recurrent Breast Carcinoma)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04692103Serial FES PET/CT to Measure Hormone Expression in Patients Undergoing Endocrine Targeted TherapyDiagnostic